Global Commercial Lead, General Manager And Head Of Commercial U.S / Canada
CurrentOversee and lead all commercial related functions in the U.S. / Canada and Global Commercial Lead. Pharvaris is a clinical-stage company focused on the discovery and development of DEUCRICTIBANT (novel oral bradykinin B2-receptor antagonists) for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.